SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a… Read more
Market Cap & Net Worth: SCHOTT Pharma AG & Co. KGaA (1SXP)
SCHOTT Pharma AG & Co. KGaA (XETRA:1SXP) has a market capitalization of $2.07 Billion (€2.01 Billion) as of March 19, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #10532 globally and #1124 in its home market, demonstrating a -3.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCHOTT Pharma AG & Co. KGaA's stock price €13.36 by its total outstanding shares 150614616 (150.61 Million).
SCHOTT Pharma AG & Co. KGaA Market Cap History: 2023 to 2026
SCHOTT Pharma AG & Co. KGaA's market capitalization history from 2023 to 2026. Data shows change from $5.17 Billion to $2.07 Billion (-29.03% CAGR).
SCHOTT Pharma AG & Co. KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCHOTT Pharma AG & Co. KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.06x
SCHOTT Pharma AG & Co. KGaA's market cap is 4.06 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
25.99x
SCHOTT Pharma AG & Co. KGaA's market cap is 25.99 times its annual earnings
830.37x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $5.17 Billion | $898.60 Million | $151.84 Million | 5.76x | 34.08x |
| 2024 | $3.89 Billion | $957.09 Million | $149.69 Million | 4.06x | 25.99x |
Competitor Companies of 1SXP by Market Capitalization
Companies near SCHOTT Pharma AG & Co. KGaA in the global market cap rankings as of March 19, 2026.
Key companies related to SCHOTT Pharma AG & Co. KGaA by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
SCHOTT Pharma AG & Co. KGaA Historical Marketcap From 2023 to 2026
Between 2023 and today, SCHOTT Pharma AG & Co. KGaA's market cap moved from $5.17 Billion to $ 2.07 Billion, with a yearly change of -29.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.07 Billion | -11.52% |
| 2025 | €2.33 Billion | -39.98% |
| 2024 | €3.89 Billion | -24.83% |
| 2023 | €5.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of SCHOTT Pharma AG & Co. KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.07 Billion USD |
| MoneyControl | $2.07 Billion USD |
| MarketWatch | $2.07 Billion USD |
| marketcap.company | $2.07 Billion USD |
| Reuters | $2.07 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.